VolitionRX Ltd’s filing revealed that its President and CEO Reynolds Cameron John acquired Company’s shares for reported $7372.0 on Jun 12 ’25. In the deal valued at $0.59 per share,12,500 shares were bought. As a result of this transaction, Reynolds Cameron John now holds 2,331,722 shares worth roughly $1.73 million.
Then, Innes Guy Archibald bought 20,000 shares, generating $10,772 in total proceeds. Upon buying the shares at $0.54, the Director now owns 888,689 shares.
Before that, Micallef Jacob Vincent bought 50,000 shares. VolitionRX Ltd shares valued at $21,500 were divested by the Chief Scientific Officer at a price of $0.43 per share. As a result of the transaction, Micallef Jacob Vincent now holds 426,033 shares, worth roughly $0.32 million.
H.C. Wainwright initiated its VolitionRX Ltd [VNRX] rating to a Buy in a research note published on April 08, 2025; the price target was $2.50. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who decreased its forecast for the stock in early February from “a Buy” to “a Hold”. Cantor Fitzgerald started covering the stock on March 10, 2021. It rated VNRX as “an Overweight”.
Price Performance Review of VNRX
On Tuesday, VolitionRX Ltd [AMEX:VNRX] saw its stock fall -4.62% to $0.74. Over the last five days, the stock has gained 14.43%. VolitionRX Ltd shares have risen nearly 12.85% since the year began. Nevertheless, the stocks have risen 23.20% over the past one year. While a 52-week high of $0.94 was reached on 06/23/25, a 52-week low of $0.40 was recorded on 05/19/25.
Levels Of Support And Resistance For VNRX Stock
The 24-hour chart illustrates a support level at 0.7241, which if violated will result in even more drops to 0.7090. On the upside, there is a resistance level at 0.7694. A further resistance level may holdings at 0.7996.
How much short interest is there in VolitionRX Ltd?
A steep rise in short interest was recorded in VolitionRX Ltd stocks on 2025-06-30, growing by 0.1 million shares to a total of 0.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 0.19 million shares. There was a rise of 35.95%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 16, 2018 when Maxim Group began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
